LS Mtron Participates in ‘Agritechnica 2019’ Accelerating Its Advance into Europe
LS Mtron (CEO Andy Kim) announced on November 28 that it had participated in ‘Agritechnica 2019’ held in Hanover, Germany from November 10 through the 16.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20191128005173/en/
LS Mtron of Korea, specializing in industrial machines and state-of-the-art components, participated in ‘Agritechnica 2019’. The company has participated in the exhibition since 2015. This year, LS Mtron had a booth covering 205 square meters to showcase its products. Under banners reading “Change Your Standard,” LS Mtron exhibited products that stressed both ‘reliability’ and ‘rationality’. In particular, tractors featuring innovative futuristic design and technology were favorably received by visitors. (Photo: Business Wire)
Under banners reading “Change Your Standard,” LS Mtron exhibited products that stressed both ‘reliability’ and ‘rationality’. In particular, tractors featuring innovative futuristic design and technology were favorably received by visitors.
In 2003, LS Mtron was spun off from LG Group as an affiliate specializing in industrial machines and state-of-the-art components. Last year, sales amounted to KRW1.1 trillion. LS Mtron, with its annual production capacity of 50,000 units, has the largest share of the Korean tractor market. The company also exports to more than 40 countries, including the US, Brazil, China, etc., with its global production and sales bases playing key roles.
Significantly, last year, LS Mtron received the ‘Tractor of the Year’ award at the North American Equipment Dealers Association’s ‘Dealer’s Choice’ awards for the 5th consecutive years. In addition, LS Mtron is ‘Korea’s No.1 Tractor’ maker that is using ICT technology to lead the agricultural machinery industry in remote diagnostic services and cutting-edge autonomous tractor technologies.
This year, LS Mtron had a booth covering 205m2 to showcase its products in ‘Agritechnica 2019’. The slogan for the event ‘Change Your Standard’ was chosen to present maximum reliability and rationality to European customers and change the anchor purchases with excellent product fundamentals, innovative design, compelling performance, full support for dealers, and supplying parts at the right place at the right time.
LS Mtron introduced 7 models ranging from an 18ps Sub-compact model to the 150ps Row-crop model which can appeal to European customers. The futuristic ‘MTX (tentative)’ concept tractor is thought to have taken the streamlined design of existing products a step further. The company has applied a strong and sharp design language with headlamps resembling the fierce eyes of an angry bull that clearly say that LS Mtron products can provide ‘powerful and faithful work performance’. The Utility tractor, 100ps ‘XP’ model, scheduled to be launched in Europe in 2020 especially drew the attention of visitors. The XP tractor, based on its powerful engine and cutting-edge technology, makes it possible to move forward and backward easily without the manual operation of clutches when using the improved power shuttle. And as it comes standard with LED headlamps instead of halogen, its workability at night has also been improved.
In particular, during the exhibition, LS Mtron entered into an MOU for the development of e-Tractors with Austria’s AVL, the world’s best powertrain development and testing company. The two companies are planning to capitalize on this MOU to develop Sub-Compact e-Tractors and produce highly-efficient and eco-friendly tractors. LS Mtron will proactively present the direction of its eco-friendly models of the future to the European market and introduce a broader lineup of various models to make inroads into the lawn & garden and landscaping markets.
LS Mtron is planning to leverage its participation in the exhibition to develop new models and technologies customized for Europe. The company has established a roadmap for the launch of new models starting with the new premium MT2 and utility tractors in 2020 and plans to proactively respond to environmental protection and regulatory changes by successively launching new models based on the Stage V engine in 2021. In January 2020, LS Mtron will become the first Korean company in the industry to restrict the use of hazardous materials containing phthalates, thereby promoting the safety of customers and eco-friendliness.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191128005173/en/
Contact information
LS Mtron
Jae Woo Lee
+82-31-8045-9667
unforgiven81@lsmtron.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Meiji Seika Pharma Partners With MBC BioLabs to Strengthen Global Innovation in Drug Discovery19.12.2025 03:00:00 EET | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Chuo-ku, Tokyo; President & CEO: Toshiaki Nagasato) today announced that it has entered into a partnership agreement with MBC BioLabs which is a private organization supporting the development of biotech startup companies in California’s San Francisco Bay Area. MBC BioLabs provides fully equipped research facilities and a supportive community that help biotech entrepreneurs accelerate from concept to company. By removing the burden of building and maintaining laboratory infrastructure, resident companies can focus early on research and development while efficiently advancing commercialization. Through this partnership, Meiji Seika Pharma will further advance its open-innovation initiatives and strengthen research and development in its priority therapeutic areas: infectious diseases, hematologic diseases, and immune-inflammatory diseases. By engaging with the entrepreneurs and startup community at MBC BioLabs, the company aims to discover inn
Enry's Island SpA Strengthens Its Leadership in Venture Capital with Explosive Growth and Redesigns the Future of VC Through Gaming19.12.2025 01:34:00 EET | Press release
Enry’s Island SpA (WBAG:EIOS), the world’s first publicly listed venture builder, announces a new era of growth, innovation, and the democratization of Venture Capital (VC). The company has delivered exceptional results, consolidating its position as an industry leader through a strategic positioning in the rapidly expanding gaming market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218742236/en/ Record Growth and Performance Enry’s Island SpA has demonstrated an extraordinary growth trajectory and a strong financial and operational track record: Revenues: +250% year-over-year (YoY). Exit: $3.6M in exits realized via IPO. Portfolio: 1 IPO of a portfolio company completed in December 2024, with an additional 2 IPOs expected in 2026. The performance of the EIOS:VSE stock reflects this strength: Price per Share (PPS): +132% in the first half (H1) of 2025, stabilizing at a +116% YTD increase. Daily Trading Volume: peaks of
500 Global Expands Africa Presence; Selected to Advance Digital Morocco 2030 Strategy18.12.2025 22:37:00 EET | Press release
500 Global, one of the world’s most active venture capital firms1, announced it has been selected to support the Ministry-led Startup VB initiative, a flagship program under the Digital Morocco 2030 strategy2. This announcement marks a significant milestone in 500 Global’s continued expansion across the African continent and its work collaborating with governments to strengthen national innovation ecosystems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218363323/en/ Announcement of 500 Global's continued expansion across Africa and support of Digital Morocco 2030 Launched by the Ministry of Digital Transition and Administrative Reform (Ministry) and deployed by TAMWILCOM, the Startup VB initiative is a flagship program under the Digital Morocco 2030 strategy. Startup VB aims to strengthen Morocco’s innovation and digital competitiveness by accelerating high-potential founders and providing the training and financing pa
Neural Concept Closes $100M Funding Round Led by Growth Equity at Goldman Sachs Alternatives to Scale AI-Native Engineering18.12.2025 18:00:00 EET | Press release
Neural Concept, a global AI platform and leader in Engineering Intelligence powering next-generation product development, today announced it raised a $100 million Series C funding round led by Growth Equity at Goldman Sachs Alternatives, with existing investors Forestay Capital, Alven, HTGF, D.E. Shaw Ventures and Aster Capital. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251218764112/en/ Image courtesy of Neural Concept (L-R clockwise from top) Jonathan Donier, CSO & Co-founder; Thomas von Tschammer, Managing Director US & Co-founder; Théophile Allard, CTO & Co-founder; Pierre Baqué CEO & Co-founder; Philippe Cuendet, COO Neural Concept is redefining engineering workflows with CAD-native enterprise AI that understands geometry, constraints and design intent. By helping its customers build and deploy physics-aware design copilots, the platform enables teams to explore millions of design options earlier and avoid costly la
Croma-Pharma Introduces New Medical Device for the Preparation of Autologous PRP | Fluid- PRF18.12.2025 17:57:00 EET | Press release
Croma-Pharma, a global player in minimally invasive aesthetic medicine, proudly announces the launch of its new medical device that is used for the preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin (Fluid-PRF).1 This launch represents continued progress in Croma’s mission to provide healthcare professionals state-of-the-art tools for their practice. With its innovative design and optimized separation technology, Exprecell™ enables the efficient preparation of autologous blood concentrates, without the use of anticoagulants, resulting in the formation of Fluid-PRF, a biologically active concentrate that retains the regenerative properties of platelets and leukocytes, yet stays liquid for a defined period.1 What makes Exprecell™ special? MDR certification: Exprecell™ is MDR-certified, meeting stringent EU regulatory requirements to ensure the safe, controlled and standardized preparation of autologous Platelet-Rich Plasma (PRP) | Fluid-Platelet-Rich Fibrin
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
